Current Report Filing (8-k)
May 31 2022 - 9:06AM
Edgar (US Regulatory)
0001420520
false
0001420520
2022-05-31
2022-05-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or
15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
May 31, 2022
ATOMERA
INCORPORATED
(Exact Name of Registrant
as Specified in Its Charter)
Delaware |
001-37850 |
30-0509586 |
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
750 University Avenue,
Suite 280
Los Gatos, California
95032
(Address of principal executive
offices)
(408) 442-5248
(Registrant’s telephone
number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant
to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common stock: Par value $0.001 |
|
ATOM |
|
Nasdaq Global Market |
Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or
Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 1.01 | Entry into a Material Definitive Agreement. |
On May 31, 2022, Atomera Incorporated (the “Company”)
entered into an Equity Distribution Agreement (the “Agreement”) with Oppenheimer & Co. Inc. and Craig-Hallum Capital Group
LLC (“Agents”) under which the Company may offer and sell, from time to time at its sole discretion, shares of its $0.001
par value common stock (“Common Stock”), to or through the Agents, as its sales agents, having an aggregate offering price
of up to $50,000,000.
Pursuant to the Agreement, sales of the Common
Stock, if any, will be made under the Company’s effective Registration Statement on Form S-3 (File No. 333-262750), previously
filed with the Securities and Exchange Commission on February 15, 2022, and the prospectus supplement relating to this offering, filed
on May 31, 2022, by any method that is deemed to be an “at the market offering” as defined in Rule 415(a)(4) under the Securities
Act of 1933, as amended, including privately negotiated and block transactions. The Agents will use commercially reasonable efforts to
sell the Common Stock from time to time, based upon instructions from the Company (including any price, time or size limits or other customary
parameters or conditions the Company may impose). The Company will pay the Agents a commission of three percent (3.0%) of the gross sales
proceeds of any Common Stock sold through the Agents under the Agreement, and also has provided the Agents with customary indemnification
rights. The Company will also reimburse the Agents for certain specified expenses in connection with entering into the Agreement up to
a maximum of $75,000.
The foregoing description of the Agreement is
not complete and is qualified in its entirety by reference to the full text of the Agreement, a copy of which is filed herewith as Exhibit
1.1 to this Current Report on Form 8-K and is incorporated herein by reference.
A copy of the legal opinion and consent of Greenberg
Traurig, LLP relating to the shares is attached hereto as Exhibit 5.1.
This Current Report on Form 8-K shall not constitute
an offer to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any offer, solicitation, or
sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any such state.
Item 9.01 Financial Statements and Exhibits
The following exhibits are filed with this report:
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned, hereunto duly authorized.
|
ATOMERA INCORPORATED |
|
|
|
|
|
|
|
Dated: May 31, 2022 |
/s/ Francis B. Laurencio |
|
|
Francis B. Laurencio,
Chief Financial Officer |
|
Atomera (NASDAQ:ATOM)
Historical Stock Chart
From Oct 2024 to Nov 2024
Atomera (NASDAQ:ATOM)
Historical Stock Chart
From Nov 2023 to Nov 2024